These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2691730)

  • 1. Latent prostatic carcinoma: pathological and epidemiological aspects.
    Yatani R; Kusano I; Shiraishi T; Hayashi T; Stemmermann GN
    Jpn J Clin Oncol; 1989 Dec; 19(4):319-26. PubMed ID: 2691730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of impalpable carcinoma of the prostate and of non-malignant and precarcinomatous lesions in Greek male population: an autopsy study.
    Stamatiou K; Alevizos A; Agapitos E; Sofras F
    Prostate; 2006 Sep; 66(12):1319-28. PubMed ID: 16688747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preneoplastic lesions of the prostate-clinical, pathological and molecular biological aspects.
    Nasir A; Copeland J; Gillespie JW; Chughtai OR; Andrawis R; Kaiser HE; Manyak MJ
    In Vivo; 2002; 16(6):557-66. PubMed ID: 12494901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Precancerous conditions of the prostate--histologic and morphometric investigation].
    Gundorova LV
    Vopr Onkol; 2003; 49(6):738-42. PubMed ID: 14976919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathology and heredity of breast cancer in younger women.
    Marcus JN; Watson P; Page DL; Lynch HT
    J Natl Cancer Inst Monogr; 1994; (16):23-34. PubMed ID: 7999466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A theoretical rationale on the histogenesis of premalignant lesions and early carcinoma of the prostate.
    Botticelli AR
    Pathologica; 1994 Apr; 86(2):128-41. PubMed ID: 7524011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of androgen receptor gene mutations in latent prostatic carcinomas from Japanese men.
    Takahashi H; Furusato M; Allsbrook WC; Nishii H; Wakui S; Barrett JC; Boyd J
    Cancer Res; 1995 Apr; 55(8):1621-4. PubMed ID: 7712463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostatic intraepithelial neoplasia is a risk factor for cancer.
    Bostwick DG
    Semin Urol Oncol; 1999 Nov; 17(4):187-98. PubMed ID: 10632120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Premalignant lesions of prostate and their association with nodular hyperplasia and carcinoma prostate.
    Rekhi B; Jaswal TS; Arora B
    Indian J Cancer; 2004; 41(2):60-5. PubMed ID: 15318010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of human papillomavirus infection in prostate cancer.
    Al-Maghrabi JA
    Saudi Med J; 2007 Mar; 28(3):326-33. PubMed ID: 17334454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Premalignant and benign lesions in nodules of adenomatous hyperplasia].
    Miján Ortiz JL; Fernández Rodríguez A; Fernández Ruiz PL; de la Fuente Serrano A; Nogales Fernández F; Zuluaga Gómez A
    Arch Esp Urol; 1996 Sep; 49(7):684-7. PubMed ID: 9020004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronological changes in latent prostatic carcinoma found in surgical specimens from Japanese during 28 years.
    Komatsu H; Horiuchi S; Nakazawa H; Oyamatsu T; Nakagawa K; Yoshino S; Fujime M
    Jpn J Clin Oncol; 1983 Jun; 13(2):411-5. PubMed ID: 6887559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between atypical adenomatous hyperplasia (AAH), prostatic intraepithelial neoplasia (PIN) and prostatic adenocarcinoma.
    Helpap B; Bonkhoff H; Cockett A; Montironi R; Troncoso P; Waters D; Bostwick D
    Pathologica; 1997 Jun; 89(3):288-300. PubMed ID: 9270265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of impalpable prostate adenocarcinoma and precancerous conditions in Greek male population: an autopsy study.
    Stamatiou K; Alevizos A; Perimeni D; Sofras F; Agapitos E
    Prostate Cancer Prostatic Dis; 2006; 9(1):45-9. PubMed ID: 16314890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations among benign prostate hypertrophy, atypical adenomatous hyperplasia and latent carcinoma of the prostate.
    Stamatiou K; Alevizos A; Natzar M; Mihas C; Mariolis A; Michalodimitrakis E; Sofras F
    Asian J Androl; 2007 Mar; 9(2):229-33. PubMed ID: 16751999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathology of incidental carcinoma.
    Bostwick DG
    Cancer Surv; 1995; 23():7-18. PubMed ID: 7621475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathology and epidemiology of prostatic cancer].
    Böcking A
    Radiologe; 1984 Jan; 24(1):5-12. PubMed ID: 6709880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The incidences of benign prostatic hyperplasia and prostatic cancer in China].
    Gu FL
    Zhonghua Wai Ke Za Zhi; 1993 Jun; 31(6):323-6. PubMed ID: 7508844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Natural follow-up of prostate cancer and consequences for early detection].
    Schmid HP
    Schweiz Rundsch Med Prax; 1993 Nov; 82(44):1239-43. PubMed ID: 7505945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.